Inhibition by transforming growth factor (34-43)-a, a TGF-α antagonist, of gastric carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine in Wistar rats
1998

Inhibition of Gastric Cancer in Rats by TGF-α Antagonist

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): M Tatsuta, H Iishi, M Babal, R Hirasawa, K Iseki, H Yanol, N Sakai, H Uehara, A Nakaizumi

Primary Institution: Osaka Medical Centre for Cancer and Cardiovascular Diseases

Hypothesis

Can TGF(34-43)-a inhibit gastric carcinogenesis induced by MNNG in Wistar rats?

Conclusion

Long-term administration of TGF(34-43)-a significantly reduced the incidence of gastric cancers in rats treated with MNNG.

Supporting Evidence

  • TGF(34-43)-a significantly reduced the incidence of gastric cancers in treated rats.
  • Administration of TGF(34-43)-a decreased cell proliferation in gastric cancers.
  • TGF(34-43)-a increased the apoptotic index in gastric cancers.

Takeaway

This study found that a special protein can help stop stomach cancer from growing in rats.

Methodology

Wistar rats were treated with MNNG and then given TGF(34-43)-a injections to observe the effects on gastric cancer development.

Limitations

The study was conducted only on rats, which may not fully represent human responses.

Participant Demographics

Male Wistar rats, aged 6 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.02

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication